Marlowe W. Eldridge

Marlowe W. Eldridge

Auto-generated profile, based on publicly available information

Marlowe W. Eldridge

University of Wisconsin-Madison

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AMAshley Mulchrone
Ashley Mulchrone
ABAlessandro Bellofiore
Alessandro Bellofiore
JDJohannes Menno Douwes
Johannes Menno Douwes
NDNeal Duong
Neal Duong
ABArij G. Beshish
Arij G. Beshish
NCNaomi C. Chesler
Naomi C. Chesler

1 October 2024 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
JMJessica D. Muer
Jessica D. Muer
KDKaylin D. Didier
Kaylin D. Didier
BWBrett M. Wannebo
Brett M. Wannebo
SSSophie Sanchez
Sophie Sanchez
HMHedyeh Khademi Motlagh
Hedyeh Khademi Motlagh
WSWilliam G. Schrage
William G. Schrage
MRI used to measure cerebral blood flow (CBF) in gray matter, white matter, and 68 regions in healthy men and women. This study demonstrated that CBF is 40% higher in women, the highest sex difference reported, when controlling for numerous important clinical confounders like age, smoking, menstrual cycle, comorbidities, and medications.

13 October 2021 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
KCKatrina J. Carter
Katrina J. Carter
AWAaron T. Ward
Aaron T. Ward
JKJ. Mikhail Kellawan
J. Mikhail Kellawan
MEMarlowe W. Eldridge
Marlowe W. Eldridge
AAAwni Al‐Subu
Awni Al‐Subu
WSWilliam G. Schrage
William G. Schrage

20 June 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
KMKent J. MacLaughlin
Kent J. MacLaughlin
GBGregory Barton
Gregory Barton
RBRudolf K. Braun
Rudolf K. Braun
JMJulia E. MacLaughlin
Julia E. MacLaughlin
JLJacob J. Lamers
Jacob J. Lamers
MEMarlowe W. Eldridge
Marlowe W. Eldridge
Introduction: Hyperbaric air (HBA) was first used pharmaceutically in 1662 to treat lung disease. Extensive use in Europe and North America followed throughout the 19th century to treat pulmonary and neurological disorders. HBA reached its zenith in the early 20th century when cyanotic, moribund “Spanish flu pandemic” patients turned normal color and regained consciousness within minutes after HBA treatment. Since that time the 78% Nitrogen fraction in HBA has been completely displaced by 100% oxygen to create the modern pharmaceutical hyperbaric oxygen therapy (HBOT), a powerful treatment that is FDA approved for multiple indications. Current belief purports oxygen as the active element mobilizing stem progenitor cells (SPCs) in HBOT, but hyperbaric air, which increases tensions of both oxygen and nitrogen, has been untested until now. In this study we test HBA for SPC mobilization, cytokine and chemokine expression, and complete blood count.Methods: Ten 34–35-year-old healthy volunteers were exposed to 1.27ATA (4 psig/965 mmHg) room air for 90 min, M-F, for 10 exposures over 2-weeks. Venous blood samples were taken: (1) prior to the first exposure (served as the control for each subject), (2) directly after the first exposure (to measure the acute effect), (3) immediately prior to the ninth exposure (to measure the chronic effect), and (4) 3 days after the completion of tenth/final exposure (to assess durability). SPCs were gated by blinded scientists using Flow Cytometry.Results: SPCs (CD45dim/CD34+/CD133-) were mobilized by nearly two-fold following 9 exposures (p = 0.02) increasing to three-fold 72-h post completion of the final (10th) exposure (p = 0.008) confirming durability.Discussion: This research demonstrates that SPCs are mobilized, and cytokines are modulated by hyperbaric air. HBA likely is a therapeutic treatment. Previously published research using HBA placebos should be re-evaluated to reflect a dose treatment finding rather than finding a placebo effect. Our findings of SPC mobilization by HBA support further investigation into hyperbaric air as a pharmaceutical/therapy.

21 October 2021 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
JMJacob A. Macdonald
Jacob A. Macdonald
GRGrant S. Roberts
Grant S. Roberts
PCPhilip Corrado
Philip Corrado
ABArij G. Beshish
Arij G. Beshish
KHKristin Haraldsdottir
Kristin Haraldsdottir
OWOliver Wieben
Oliver Wieben
Preterm birth has been linked to an elevated risk of heart failure and cardiopulmonary disease later in life. With improved neonatal care and survival, most infants born preterm are now reaching adulthood. In this study, we used 4D flow cardiovascular magnetic resonance (CMR) coupled with an exercise challenge to assess the impact of preterm birth on right heart flow dynamics in otherwise healthy adolescents and young adults who were born preterm. Eleven young adults and 17 adolescents born preterm (< 32 weeks of gestation and < 1500 g birth weight) were compared to 11 young adult and 18 adolescent age-matched controls born at term. Stroke volume, cardiac output, and flow in the main pulmonary artery were quantified with 4D flow CMR. Kinetic energy and vorticity were measured in the right ventricle. All parameters were measured at rest and during exercise at a power corresponding to 70% VO2max for each subject. Multivariate linear regression was used to perform age-adjusted term-preterm comparisons. With exercise, stroke volume increased 10 ± 21% in term controls and decreased 4 ± 18% in preterm born subjects (p = 0.007). This resulted in significantly reduced capacity to increase cardiac output in response to exercise stress for the preterm group (58 ± 26% increase in controls, 36 ± 27% increase in preterm, p = 0.004). Elevated kinetic energy (KEterm = 71 ± 22 nJ, KEpreterm = 87 ± 38 nJ, p = 0.03) and vorticity (ωterm = 79 ± 16 s−1, ωpreterm = 94 ± 32 s−1, p = 0.01) during diastole in the right ventricle (RV) suggested altered RV flow dynamics in the preterm subjects. Streamline visualizations showed altered structure to the diastolic filling vortices in those born preterm. For the participants examined here, preterm birth appeared to result in altered right-heart flow dynamics as early as adolescence, especially during diastole. Future studies should evaluate whether the altered dynamics identified here evolves into cardiopulmonary disease later in life. Trial registration None

25 October 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
JPJitandrakumar R. Patel
Jitandrakumar R. Patel
GBGregory Barton
Gregory Barton
RBRudolf K. Braun
Rudolf K. Braun
KGKara Goss
Kara Goss
KHKristin Haraldsdottir
Kristin Haraldsdottir
MEMarlowe W. Eldridge
Marlowe W. Eldridge
Infants born premature are at increased risk for development of bronchopulmonary dysplasia (BPD), pulmonary hypertension (PH), and ultimately right ventricular (RV) dysfunction, which together carry a high risk of neonatal mortality. However, the role alveolar simplification and abnormal pulmonary microvascular development in BPD affects RV contractile properties is unknown. We used a rat model of BPD to examine the effect of hyperoxia-induced PH on RV contractile properties. We measured in vivo RV pressure as well as passive force, maximum Ca2+ activated force, calcium sensitivity of force (pCa50) and rate of force redevelopment (ktr) in right ventricular skinned trabeculae isolated from hearts of 21- and 35-day old rats pre-exposed to 21% oxygen (normoxia) or 85% oxygen (hyperoxia) for 14 days after birth. Systolic and diastolic RV pressure were significantly higher at day 21 in hyperoxia exposed rats compared to normoxia control rats, but normalized by 35 days of age. Passive force, maximum Ca2+ activated force, and calcium sensitivity of force were elevated and cross-bridge cycling kinetics depressed in 21-day old hyperoxic trabeculae, whereas no differences between normoxic and hyperoxic trabeculae were seen at 35 days. Myofibrillar protein analysis revealed that 21-day old hyperoxic trabeculae had increased levels of beta-myosin heavy chain (MHC), atrial myosin light chain 1 (aMLC1; often referred to as essential light chain), and slow skeletal troponin I (ssTnI) compared to age matched normoxic trabeculae. On the other hand, 35-day old normoxic and hyperoxic trabeculae expressed similar level of - and -MHC, ventricular MLC1 and predominantly cTnI. These results suggest that neonatal exposure to hyperoxia increases RV afterload and affect both the steady state and dynamic contractile properties of the RV, likely as a result of hyperoxia-induced expression of -MHC, delayed transition of slow skeletal TnI to cardiac TnI, and expression of atrial MLC1. These hyperoxia-induced changes in contractile properties are reversible and accompany the resolution of PH with further developmental age, underscoring the importance of reducing RV afterload to allow for normalization of RV function in both animal models and humans with BPD.